Whereas vimentin concentration averaged 1462.63 ± 175.23 ng/ml in breast cancer patients and 851.29 ± 109.04 ng/ml in controls, DAPK1 concentration averaged 1105.75 ± 396.56 ng/ml and 371.09 ± 119.82 ng/ml in breast cancer patients and controls, respectively. This evidence concerns the gene VIM and breast cancer.